Novartis Loses Bid To Toss $2.6M Zometa Award

Law360, New York (January 5, 2011, 3:13 PM EST) -- Montana's highest court has upheld a $2.6 million judgment against Novartis Pharmaceuticals Corp. in a lawsuit brought by a woman who alleged she developed a painful jaw condition after taking the company's Zometa drug.

The Supreme Court of the State of Montana rejected Novartis' request for a new trial on Dec. 30. The plaintiff, Peggy L. Stevens, developed osteonecrosis of the jaw — a condition resulting in the death of the jawbone — after being given Zometa, which was supposed to increase bone strength in cancer...
To view the full article, register now.